Journal Scans
Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL
Overtreatment of Prostate Cancer With PSA ≤4.0
Y-H Shao, PC Albertsen, CB Roberts, Y Lin, AR Mehta, MN Stein, RS DiPaola, GL Lu-Yao
20100626
2010 Jul 26
Arch Intern Med
Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL
Arch Intern Med. 2010 Jul 26;170(14):1256-1261, Y-H Shao, PC Albertsen, CB Roberts, Y Lin, AR Mehta, MN Stein, RS DiPaola, GL Lu-Yao
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
The level of prostate specific antigen (PSA) that is the threshold for biopsy is 4 ng/mL. Despite the lack of established risk profiles for men with PSA <4 ng/mL, some reports have suggested reducing the threshold for biopsy to <4 ng/mL. In this nationwide study, data from the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2006 were used to investigate risk profiles and treatment patterns in men with prostate cancer whose PSA value was <4 ng/mL at diagnosis. The results...
